Chapter 13: Comprehensive Biology Notes: Microbial Pathogenicity, Infection Stages, and Epidemiology

Normal Biota and the Human Habitat

• Terminology for Human Microbes

  • The microbes that reside permanently or semi-permanently on or in the human body without causing disease under normal circumstances are referred to using several terms:

  • Normal Biota: The most common modern term for the ecological community of commensal, symbiotic, and pathogenic microorganisms.

  • Resident Biota: Microbes that are long-term inhabitants of the body.

  • Indigenous Flora: A term reflecting the idea that these microbes are "native" to the human body.

  • Normal Flora: An older term (now less favored because "flora" implies plants, and microbes are not plants).

  • Human Microbiome: Specifically refers to the collective genomes of the microbes.

• The Human Body as a Favorable Habitat

  • The human body provides a highly stable and nutrient-rich environment for microbes due to several factors:

  • Constant Temperature: Body temperature (approximately $37^{\circ}C$) is ideal for the growth of mesophilic microorganisms.

  • Abundant Nutrients: The body provides a constant supply of organic molecules through secretions, sloughed cells, and digested food.

  • High Water Activity: Most tissues are moist, providing the hydration necessary for metabolic processes.

  • Vast Surface Area: The skin and internal mucous membranes (GI tract, respiratory tract) provide millions of square millimeters for colonization.

• Viruses as Normal Residents

  • Evidence suggests that the "Human Virome" is a significant component of the normal biota.

  • Viruses are found in large numbers in the blood, feces, and skin of healthy individuals.

  • Many of these viruses are bacteriophages (infecting our resident bacteria), while others are latent mammalian viruses (such as Herpesviruses) that reside in tissues without causing active disease.

• Probiotics

  • Probiotics are defined as preparations of live microorganisms that are consumed or introduced into the body to confer a health benefit to the host.

  • They are often used to replenish the normal biota after antibiotic therapy or to treat gastrointestinal distress.

• Axenic Conditions

  • Axenic refers to a state or environment that is completely free of all living organisms other than the species being studied.

  • In a human context, "axenic animals" (germ-free animals) are raised in sterile environments to study the effects of a completely absent microbiome.

Pathogenicity and Portals of Entry

• Pathogenicity

  • Pathogenicity is the broad ability of an infectious agent to cause disease in a host.

  • This differs from virulence, which is the degree or intensity of that pathogenicity.

• Portal of Entry

  • A portal of entry is the specific route or site through which a pathogen enters the body to initiate an infection.

• Entry via the Skin

  • Pathogens enter the skin through several mechanisms:

  • Nicks and Abrasions: Physical breaks in the keratinized layer of the epidermis.

  • Punctures: Deep wounds (e.g., from needles or nails).

  • Insect Bites: Vectors like mosquitoes or ticks bypass the skin barrier directly.

  • Digestive Secretions: Some fungi can produce enzymes that digest keratin to penetrate the skin.

  • Mucous Membranes: Areas where the skin is thinner and moister (e.g., conjunctiva of the eye).

• Entry via the Gastrointestinal (GI) Tract

  • Pathogens enter through the ingestion of contaminated food or water.

  • They must survive the harsh acidic environment of the stomach (low $pH$) and the alkaline conditions/bile in the small intestine.

  • Examples include Salmonella, Shigella, and Vibrio cholerae.

• Infectious Dose ($ID$)

  • The infectious dose is the minimum number of microbial cells or particles required to cause an infection in a host.

  • Microbes with a smaller $ID$ (e.g., $ID_{10}$ to $ID_{100}$ cells) are generally considered more virulent than those with a high $ID$ (e.g., $10^8$ cells).

Adhesion and Virulence Factors

• Adhesion

  • Adhesion is the process by which microbes gain a stable foothold on host tissues.

  • Because the body has numerous flushing mechanisms (urination, coughing, sneezing, peristalsis), the microbe must attach to a specific surface.

• Virulence Factors

  • A virulence factor is any characteristic or structure of the microbe that contributes to its ability to establish itself in the host and cause damage.

• Categories of Virulence Factors

  1. Antiphagocytic Factors: Mechanisms to avoid being destroyed by host white blood cells (e.g., capsules of Streptococcus pneumoniae).

  2. Exoenzymes: Secreted enzymes that break down host tissues (e.g., hyaluronidase).

  3. Toxins: Chemicals that are poisonous to the host (e.g., botulinum toxin).

• Direct Damage to Host Tissues

  • Pathogens cause direct damage primarily through the secretion of exoenzymes and toxins.

  • Enzymes like collagenase digest connective tissue, while mucinase digests the protective coating on mucous membranes, allowing the pathogen to advance deeper into the tissue.

Resistance and Microbial Counter-Defenses

• Initial Resistance to Non-Biota

  • Microbes that are not part of the normal biota face immediate resistance from the host's immune system, primarily through the process of phagocytosis.

• Phagocytes

  • A phagocyte is a specialized type of white blood cell (such as a macrophage or neutrophil) that engulfs and destroys pathogens using digestive enzymes.

• Blocking the Phagocytic Response

  • Microbes use several strategies to block phagocytes:

  • Leukocidins: Substances produced by Staphylococcus and Streptococcus that are toxic to white blood cells.

  • Slime Layers or Capsules: These make the bacterial surface slippery, making it physically difficult for the phagocyte to grab the cell.

  • Survival Inside the Phagocyte: Some microbes (like Mycobacterium tuberculosis) allow themselves to be engulfed but then prevent the fusion of the phagosome with the lysosome, living and multiplying inside the host cell.

Toxins and Bacterial Components

• Exoenzymes

  • An exoenzyme is an enzyme secreted by a microbe into the surrounding environment to break down host molecules and assist in tissue penetration.

• Toxins and Toxinoses

  • Toxin: A specific chemical product of microbes, plants, or some animals that is poisonous to other organisms.

  • Toxinoses: Diseases caused by the effects of toxins (e.g., Tetanus, Botulism).

• Exotoxins vs. Endotoxins

  • Exotoxin: A toxin molecule secreted by a living bacterial cell into the infected tissues. They are usually proteins with high specificity for target cells (e.g., neurotoxins acting on nerves).

  • Endotoxin: A toxin that is not actively secreted but is released only after the bacterial cell is damaged or dies. It has systemic effects like fever and inflammation.

• Lipopolysaccharide (LPS)

  • LPS is the specific chemical structure that functions as the primary endotoxin.

  • Location: It is located in the outer membrane of the cell wall.

  • Bacterial Type: LPS is found exclusively in Gram-negative bacteria.

Stages of Infection

• Typical Stages

  1. Incubation Period: The time from the initial contact with the infectious agent to the appearance of the first symptoms. The microbe is multiplying but has not caused enough damage to elicit symptoms.

  2. Prodromal Stage: A short period (1–2 days) characterized by the earliest, notable symptoms, such as vague aches and fatigue.

  3. Period of Invasion: The height of the infection. The microbe multiplies at high levels and exhibits its greatest toxicity; specific signs and symptoms appear (e.g., high fever, rash, swelling).

  4. Convalescent Period: The recovery phase where the patient's immune system begins to respond, the symptoms decline, and the patient's health is gradually restored.

Indicators and Manifestations of Disease

• Localized Infection

  • An infection where the microbe enters the body and remains confined to a specific tissue or area (e.g., a boil or a wart).

• Signs vs. Symptoms

  • Symptom: A subjective evidence of disease as sensed by the patient (e.g., pain, nausea, headache). Only the patient can "feel" these.

  • Sign: Any objective evidence of disease as noted by an observer (e.g., fever, chest sounds, swollen lymph nodes, high white blood cell count).

  • Syndrome: A specific group of signs and symptoms that characterize a particular disease.

• Inflammation

  • Inflammation is a natural host defense response to tissue injury or infection. It is characterized by signs such as edema (swelling), granulomas/abscesses, and lymphadenitis (swollen lymph nodes).

• Signs of Blood Infection

  • Leukocytosis: An abnormal increase in white blood cells.

  • Leukopenia: An abnormal decrease in white blood cells.

  • Septicemia: A general state where microorganisms are multiplying in the blood and are present in large numbers.

  • Bacteremia/Viremia: Small numbers of bacteria or viruses present in the blood, but not necessarily multiplying.

• Asymptomatic Infections

  • It is common for an infection to go unnoticed by the patient (subclinical or inapparent infections), even though the pathogen is active in the host.

Transmission and Epidemiology

• Portal of Exit

  • A portal of exit is the specific route through which a pathogen leaves the host to infect others (e.g., respiratory droplets, feces, skin scales, blood).

• Latency

  • Latency is a state of persistence where the microbe remains in the host in a dormant or inactive state for long periods (e.g., Chronic viral infections like HIV or Herpes simplex).

• Epidemiology

  • Epidemiology is the study of the frequency and distribution of disease and other health-related factors in defined human populations.

• Reservoirs and Carriers

  • Reservoir: The primary natural habitat in the world from which a pathogen originates (e.g., soil, water, humans, or animals).

  • Carrier: An individual who inconspicuously shelters a pathogen and spreads it to others without even knowing it.

• Surveillance and Prevalence

  • Surveillance: The systematic collection, analysis, and interpretation of health data to track the progress of diseases.

  • Prevalence: The total number of existing cases with respect to the entire population, usually represented as a percentage ($\text{Prevalence} = \frac{\text{Total number of cases in population}}{\text{Total number of persons in population}} \times 100$).

• Health-Care-Associated Infections (HAI)

  • Formerly known as nosocomial infections, these are infectious diseases that are acquired or developed during a stay in a medical facility (hospital, clinic, or nursing home).